FIGS, Inc. shares rose after the direct-to-consumer healthcare apparel company reported strong second-quarter financial results, according to an investor letter released by Baron Capital for the Baron Focused Growth Fund.
The Bottom Line:
- Net revenue grew 28.8% year-over-year, driven by higher order volumes and average order value.
- Adjusted EBITDA margin expanded 570 basis points to 18.6%, supported by full-price selling and lower returns.
- Management raised its full-year revenue growth outlook to approximately 20% from the previous range of 14% to 16%.
Scrubwear revenue increased 26.5%, while non-scrubwear products recorded a 40.3% gain and international sales jumped 67%.
Active customers increased 13% to approximately 3.1 million. At the same time, revenue per active customer reached a record high, according to the fund’s Q3 2026 investor letter.
Profitability metrics showed substantial improvement alongside top-line gains. Expense leverage and lower return rates contributed to the wider adjusted EBITDA margin.
The Baron Focused Growth Fund declined 2.34% for its institutional shares during the third quarter, outperforming the Russell 2500 Growth Index drop of 10.35%. Portfolio managers pointed to concerns over artificial intelligence capital spending and macroeconomic pressures on consumer spending as headwinds for the period.

On November 16, 2026, FIGS, Inc. (NYSE:FIGS) closed at $21.34 per share with a market capitalization of $3.54 billion, Yahoo Finance reported. Over the past month, the stock gained 7.45%, extending its 52-week gain to 134.25% amid a sharp turnaround rally.
“FIGS, Inc., a direct-to-consumer health care apparel brand, contributed to performance following a strong second quarter. Net revenue grew 28.8% year-over-year, driven by higher order volumes and average order value. Growth was broad-based, with scrubwear revenue up 26.5%, non-scrubwear up 40.3%, and international sales up 67%. Active customers increased 13% to approximately 3.1 million, while revenue per active customer reached a record high. Profitability also improved, with adjusted EBITDA margin expanding 570 basis points to 18.6%, reflecting full price selling, lower returns, and expense leverage. Management raised its full-year revenue growth outlook to approximately 20% from the 14% to 16% range. We retain strong conviction in FIGS’ business model and the company’s ability to gain market share in the attractive global health care apparel industry.”
As of September 30, 2026, the Baron Focused Growth Fund held top 10 positions comprising 66.5% of its net assets. The portfolio continues to target high-growth opportunities trading at low multiples.
Disclaimer: The information provided in this article is for educational and market analysis purposes only and does not constitute financial, investment, or legal advice. Always consult with a certified financial professional before making investment decisions.